Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Children with attention deficits concentrate better after walk in the park.

Taylor AF, Kuo FE.

J Atten Disord. 2009 Mar;12(5):402-9. doi: 10.1177/1087054708323000. Epub 2008 Aug 25.

PMID:
18725656
2.

Efficacy of methylphenidate, psychosocial treatments and their combination in school-aged children with ADHD: a meta-analysis.

Van der Oord S, Prins PJ, Oosterlaan J, Emmelkamp PM.

Clin Psychol Rev. 2008 Jun;28(5):783-800. Epub 2007 Nov 6.

PMID:
18068284
3.
4.

[The effects of methylphenidate on various components of visual attention in children with attention-deficit hyperactivity disorder].

Durukan I, Türkbay T, Cöngöloğlu A.

Turk Psikiyatri Derg. 2008 Winter;19(4):358-64. Turkish.

5.

The effect of methylphenidate on postural stability under single and dual task conditions in children with attention deficit hyperactivity disorder - a double blind randomized control trial.

Jacobi-Polishook T, Shorer Z, Melzer I.

J Neurol Sci. 2009 May 15;280(1-2):15-21. doi: 10.1016/j.jns.2009.01.007. Epub 2009 Feb 13.

PMID:
19217632
6.

Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.

Adler LA, Zimmerman B, Starr HL, Silber S, Palumbo J, Orman C, Spencer T.

J Clin Psychopharmacol. 2009 Jun;29(3):239-47. doi: 10.1097/JCP.0b013e3181a390ce.

PMID:
19440077
7.

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder.

Rösler M, Fischer R, Ammer R, Ose C, Retz W.

Eur Arch Psychiatry Clin Neurosci. 2009 Mar;259(2):120-9. doi: 10.1007/s00406-008-0845-4. Epub 2009 Jan 22. Erratum in: Eur Arch Psychiatry Clin Neurosci. 2009 Sep;259(6):368.

PMID:
19165529
8.

Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.

Chou WJ, Chou MC, Tzang RF, Hsu YC, Gau SS, Chen SJ, Wu YY, Huang YF, Liang HY, Cheng H.

Psychiatry Clin Neurosci. 2009 Apr;63(2):167-75. doi: 10.1111/j.1440-1819.2009.01937.x.

9.

A meta-analysis of combined treatments for children diagnosed with ADHD.

Majewicz-Hefley A, Carlson JS.

J Atten Disord. 2007 Feb;10(3):239-50.

PMID:
17242418
10.

Efficacy of osmotic-release oral system (OROS) methylphenidate for mothers with attention-deficit/hyperactivity disorder (ADHD): preliminary report of effects on ADHD symptoms and parenting.

Chronis-Tuscano A, Seymour KE, Stein MA, Jones HA, Jiles CD, Rooney ME, Conlon CJ, Efron LA, Wagner SA, Pian J, Robb AS.

J Clin Psychiatry. 2008 Dec;69(12):1938-47. Epub 2008 Dec 2.

PMID:
19192455
11.

A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder.

Kahbazi M, Ghoreishi A, Rahiminejad F, Mohammadi MR, Kamalipour A, Akhondzadeh S.

Psychiatry Res. 2009 Aug 15;168(3):234-7. doi: 10.1016/j.psychres.2008.06.024. Epub 2009 May 12.

PMID:
19439364
12.

The effect of methylphenidate on Internet video game play in children with attention-deficit/hyperactivity disorder.

Han DH, Lee YS, Na C, Ahn JY, Chung US, Daniels MA, Haws CA, Renshaw PF.

Compr Psychiatry. 2009 May-Jun;50(3):251-6. doi: 10.1016/j.comppsych.2008.08.011. Epub 2008 Oct 15.

PMID:
19374970
13.

Child characteristics and receipt of stimulant medications: a population-based study.

Miller AR, Kohen D, Johnston C.

Ambul Pediatr. 2008 May-Jun;8(3):175-81. doi: 10.1016/j.ambp.2008.01.009. Epub 2008 Apr 14.

PMID:
18501864
14.

Social information processing in elementary-school aged children with ADHD: medication effects and comparisons with typical children.

King S, Waschbusch DA, Pelham WE Jr, Frankland BW, Andrade BF, Jacques S, Corkum PV.

J Abnorm Child Psychol. 2009 May;37(4):579-89. doi: 10.1007/s10802-008-9294-9.

PMID:
19107591
15.

Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial.

Cohen-Yavin I, Yoran-Hegesh R, Strous RD, Kotler M, Weizman A, Spivak B.

Clin Neuropharmacol. 2009 Jul-Aug;32(4):179-82. doi: 10.1097/WNF.0b013e318183796d.

PMID:
19644227
16.

An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.

Chavez B, Sopko MA Jr, Ehret MJ, Paulino RE, Goldberg KR, Angstadt K, Bogart GT.

Ann Pharmacother. 2009 Jun;43(6):1084-95. doi: 10.1345/aph.1L523. Epub 2009 May 26. Review.

PMID:
19470858
17.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
18.

Association between homozygosity of a G allele of the alpha-2a-adrenergic receptor gene and methylphenidate response in Korean children and adolescents with attention-deficit/hyperactivity disorder.

Cheon KA, Cho DY, Koo MS, Song DH, Namkoong K.

Biol Psychiatry. 2009 Apr 1;65(7):564-70. doi: 10.1016/j.biopsych.2008.12.003. Epub 2009 Jan 15.

PMID:
19150055
19.

[Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].

Stasik D, Tucha O, Tucha L, Walitza S, Lange KW.

Psychiatr Pol. 2009 Mar-Apr;43(2):183-92. Review. Polish.

PMID:
19697788
20.

No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy.

Walitza S, Kämpf K, Artamonov N, Romanos M, Gnana Oli R, Wirth S, Warnke A, Gerlach M, Stopper H.

Toxicol Lett. 2009 Jan 10;184(1):38-43. doi: 10.1016/j.toxlet.2008.10.011. Epub 2008 Oct 28.

PMID:
19015014

Supplemental Content

Support Center